Search - tctmd.com

Displaying 81 - 100 of 191

Sort: Relevancy | Date

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Industry News

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

May 20, 2015

News Industry News

BIOTRONIK Announces European Launch of Pantera Pro Coronary Balloon Catheter

April 01, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

News Industry News

Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon

February 08, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

Presentation ISET 2015

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

Presenter: Thomas Zeller

February 03, 2015

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Daily News

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Yael L. Maxwell

January 28, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Industry News

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

January 04, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Presentation TCT 2014

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Marianne Brodmann

September 15, 2014

Presentation TCT 2014

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia

September 15, 2014

Advertisement

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

Studies Provide Encouraging Results for DCB in Long SFA Lesions

QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon

BIOTRONIK Announces European Launch of Pantera Pro Coronary Balloon Catheter

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon

ISET Abstracts Shed Light on Novel Therapies for PAD

Drug-Coated Balloons: How Does It Change the Treatment Landscape for CLI?

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content